Stay updated on Galidesivir Safety/PK/Antiviral Effects in Yellow Fever/COVID-19 Clinical Trial
Sign up to get notified when there's something new on the Galidesivir Safety/PK/Antiviral Effects in Yellow Fever/COVID-19 Clinical Trial page.

Latest updates to the Galidesivir Safety/PK/Antiviral Effects in Yellow Fever/COVID-19 Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision: v3.5.0 has been added, replacing the previous Revision: v3.4.3.SummaryDifference0.1%

- Check27 days agoChange DetectedRevision tag on the page was updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check49 days agoChange DetectedAdded an optional tag 'Gastric cancer' and a new 'Genetic and Rare Diseases Information Center' resource under Resources. These changes provide additional context but do not modify the trial details or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check56 days agoChange DetectedA new site revision label 'Revision: v3.4.2' has been added. A prior notice about government funding status and operating status (Revision: v3.4.1) is present, but core trial details remain unchanged.SummaryDifference0.5%

- Check63 days agoChange DetectedA system notice about potential delays due to a lapse in government funding was added, noting that the NIH Clinical Center is open and directing users to cc.nih.gov and opm.gov for updates. The revision banner now shows Revision: v3.4.1, replacing the previous v3.4.0.SummaryDifference0.5%

- Check70 days agoChange DetectedThe page now shows the glossary by default, adds a 'Last Update Submitted that Met QC Criteria' entry and a 'Revision: v3.4.0' tag, and adjusts certain labels (e.g., capitalization of 'No FEAR Act data'). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Galidesivir Safety/PK/Antiviral Effects in Yellow Fever/COVID-19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Galidesivir Safety/PK/Antiviral Effects in Yellow Fever/COVID-19 Clinical Trial page.